Darrell J. Yamashiro, MD

Darrell J. Yamashiro, MD Specialties: Pediatric Hematology-Oncology, Pediatrics, Cancer Care

Darrell J. Yamashiro, MD
Specialties: Pediatric Hematology-Oncology, Pediatrics, Cancer Care
phone icon
checkmark iconAccepting new patients
Rated one of New York Magazine's Best Doctors


161 Fort Washington Avenue
New York, NY 10032

insurance iconinsurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • Affinity Health Plan
  • Amida Care
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Oxford Health Plans
  • UnitedHealthcare
  • WellCare

about iconabout icon
About Darrell J. Yamashiro, MD

I am a pediatric oncologist who specializes in caring for children with solid tumors, especially neuroblastoma, Wilms' and other kidney tumors, and liver tumors such hepatoblastoma and hepatocellular carcinoma. I serve as chief of the Division of Hematology, Oncology and Stem Cell Transplantation at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital.

I treat children of all ages, from infants to young adults. Some of the cancers I treat are rare (liver tumors account for one to two percent of childhood cancers), but they can be very complex and require a multidisciplinary approach so patients have the best outcomes. I enjoy working as part of a team of physicians, nurse practitioners, nurses, social workers, child life specialists, and other dedicated professionals who care deeply about our patients and provide care with compassion and comfort.

I also conduct basic science research. The latest advances in tumor genetics and the design of innovative therapies make this a very exciting time for cancer research. My team and I have done extensive research on the genetics of hepatoblastoma. We have developed mouse models of this disease and are entering a new phase where we are offering a personalized/precision medicine approach to children with this disease. We are also identifying novel genes that specifically target neuroblastoma—information that may be used to create targeted therapies.

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center
  • NewYork-Presbyterian Morgan Stanley Children's Hospital


  • Angiogenesis

  • Hepatoblastoma

  • Neuroblastoma

  • Pediatric Liver Cancer

  • Pediatric Solid Tumors

  • Wilm's Tumor

Board Certifications

  • Pediatric Hematology-Oncology
  • Pediatrics